Australija - anglų - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: sodium hydroxide; soya oil; disodium edetate; glycerol; water for injections; egg lecithin - diprivan is a short-acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and in children aged three years and older. diprivan has no analgesic properties. although the safety and efficacy of diprivan in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures. indications as at 4 november 2004: induction of general anaesthesia in children and adults. diprivan is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults. diprivan is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. diprivan may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. diprivan has no analgesic properties. sedation during intensive care in adults. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: glycerol; disodium edetate; sodium hydroxide; egg lecithin; soya oil; water for injections - diprivan is a short-acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and in children aged three years and older. diprivan has no analgesic properties. although the safety and efficacy of diprivan in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures. indications as at 4 november 2004: induction of general anaesthesia in children and adults. diprivan is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults. diprivan is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. diprivan may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. diprivan has no analgesic properties. sedation during intensive care in adults. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: egg lecithin; sodium hydroxide; disodium edetate; glycerol; water for injections; soya oil - diprivan is a short-acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and in children aged three years and older. diprivan has no analgesic properties. although the safety and efficacy of diprivan in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures. indications as at 4 november 2004: induction of general anaesthesia in children and adults. diprivan is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults. diprivan is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. diprivan may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. diprivan has no analgesic properties. sedation during intensive care in adults. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: glycerol; soya oil; disodium edetate; egg lecithin; sodium hydroxide; water for injections - diprivan is a short-acting intravenous anaesthetic agent suitable for induction and maintenance of general anaethesia in adults and in children aged three years and older. diprivan has no analgesic properties. although the safety and efficacy of diprivan in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures. indications as at 4 november 2004: induction of general anaesthesia in children and adults. diprivan is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults. diprivan is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. diprivan may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. diprivan has no analgesic properties. sedation during intensive care in adults. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - propofol -

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

fresenius kabi usa, llc - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - diprivan is an iv general anesthetic and sedation drug that can be used as described in the table below.  table 3. indications for diprivan safety, effectiveness and dosing guidelines for diprivan have not been established for mac sedation in the pediatric population; therefore, it is not recommended for this use (see precautions, pediatric use ). diprivan is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations. in the intensive care unit (icu), diprivan can be administered to intubated, mechanically ventilated adult patients to provide continuous sedation and control of stress responses only by persons skilled in the medical management of critically ill patients and trained in cardiovascular resuscitation and airway management. diprivan is not indicated for use in pediatric icu sedation since the safety of this regimen has not been established (see precautions, pediatric use ). diprivan is not recommended for obstetrics, including cesarean section deliveries. diprivan crosses the placenta, and as with other general anesthetic agents, the administration of diprivan may be associated with neonatal depression (see precautions). diprivan is not recommended for use in nursing mothers because propofol has been reported to be excreted in human milk, and the effects of oral absorption of small amounts of propofol are not known (see precautions). diprivan is contraindicated in patients with a known hypersensitivity to propofol or any of diprivan components. diprivan is contraindicated in patients with allergies to eggs, egg products, soybeans or soy products. there are reports of the abuse of propofol for recreational and other improper purposes, which have resulted in fatalities and other injuries.  instances of self-administration of diprivan by health care professionals have also been reported, which have resulted in fatalities and other injuries. inventories of diprivan should be stored and managed to prevent the risk of diversion, including restriction of access and accounting procedures as appropriate to the clinical setting.

Airija - anglų - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - propofol - emulsion for inj/inf - 1 %w/v - other general anesthetics

Malta - anglų - Medicines Authority

astrazeneca uk limited - propofol 10 mg/ml - emulsion for infusion or injection

Malta - anglų - Medicines Authority

aspen pharma trading limited 3016 lake drive city west businees campus dublin 24, ireland - propofol - emulsion for infusion or injection - propofol 10 mg/ml - anesthetics

Airija - anglų - HPRA (Health Products Regulatory Authority)

aspen pharma trading limited - propofol - emulsion for injection/infusion - 1 percent weight/volume - other general anesthetics; propofol